Compare RFL & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RFL | VCIG |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Real Estate | Diversified Commercial Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.5M | 2.9M |
| IPO Year | 2017 | 2022 |
| Metric | RFL | VCIG |
|---|---|---|
| Price | $1.28 | $1.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 45.0K | ★ 227.7K |
| Earning Date | 03-16-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $917,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.81 |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $1.12 | $0.20 |
| 52 Week High | $3.19 | $23.40 |
| Indicator | RFL | VCIG |
|---|---|---|
| Relative Strength Index (RSI) | 52.47 | 41.34 |
| Support Level | $1.15 | $0.95 |
| Resistance Level | $1.34 | $1.22 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 56.76 | 35.76 |
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.